loading

Sensei Biotherapeutics Inc Azioni (SNSE) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-06-30 2024-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - -
Operating Expenses
28.43%
5.206
7.274 7.787 8.73
Interest Income/Expense
23.08%
0.01
0.013 0.024 0.028
Operating Income/Loss
28.43%
-5.206
-7.274 -7.787 -8.73
Income/Loss From Continuing Operations Before Tax
28.09%
-4.936
-6.864 -7.142 -7.992
Income Tax Expense/Benefit
-
- - -
Income/Loss From Continuing Operations After Tax
28.09%
-4.936
-6.864 -7.142 -7.992
Net Income/Loss
28.09%
-4.936
-6.864 -7.142 -7.992
Preferred Stock Dividends And Other Adjustments
-
- - -
Attributable To Noncontrolling Interest
-
- - -
Basic Average Shares
95.00%
1.2609
25.19 25.10 25.05
Diluted Average Shares
95.00%
1.2609
25.19 25.10 25.05
Basic Earnings Per Share
1,348%
-3.91
-0.27 -0.28 -0.32
Diluted Earnings Per Share
1,348%
-3.91
-0.27 -0.28 -0.32
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - -
$102.71
price up icon 28.63%
$33.90
price up icon 2.42%
$110.57
price up icon 3.67%
$100.08
price up icon 2.03%
biotechnology ONC
$333.87
price up icon 4.22%
$176.00
price up icon 0.53%
Capitalizzazione:     |  Volume (24 ore):